The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Van Deventer Sander since year 2005.
The trader's CIK number is 1543084.
At the time of this reporting, Van Deventer Sander is the Chief Scientific Officer of Uniqure N.v. .
(stock ticker symbol QURE).
See this page for all insider trading activities at Uniqure N.v. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-08-02||ARGS||Argos Therapeutics Inc||Buy||1,545,454||.00||0|
|2016-06-29||ARGS||Argos Therapeutics Inc||Buy||1,322,618||.00||0|
|2016-03-14||ARGS||Argos Therapeutics Inc||Buy||881,745||.00||0|
|2014-02-12||ARGS||Argos Therapeutics Inc||Buy||36,416||8.00||291,328|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Van Deventer Sander (Chief Scientific Officer of Uniqure N.v. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.